- Becton, Dickinson and Company (NYSE:BDX) announces additional orders in the U.S. and Canada for 177M injection devices for use during the pandemic.
- A total of 190M devices have been ordered in the U.S., including the new order for 140M units. A total of 75M have been ordered in Canada, including 37M in the new order. Most will be delivered by year-end.
- Globally, the company has received orders for 330M needles and syringes.
- Earlier this month, the company announced a $70M investment to expand production capacity at its facilities in Nebraska.
Becton, Dickinson nabs orders for 177M injection devices
Recommended For You
About BDX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BDX | - | - |
Becton, Dickinson and Company |